Respiratory Diseases Branch, Division of Bacterial Disease, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
IHRC, Atlanta, GA, USA.
Diagn Microbiol Infect Dis. 2020 Jun;97(2):115037. doi: 10.1016/j.diagmicrobio.2020.115037. Epub 2020 Mar 12.
We expanded our current Centers for Disease Control and Prevention triplexed real-time polymerase chain reaction scheme identifying 11 individual serotypes and 10 serogroups to a quadriplex format identifying 34 individual serotypes and 13 small serogroups, 4 antibiotic resistance determinants, pilus targets, and penicillin susceptibility. Newly developed assays are specific for serotypes/serogroups, are sensitive (10 copies/reaction), and further discriminate larger serogroups into individual serotypes or smaller serogroups.
我们扩展了当前的疾病控制与预防中心三联实时聚合酶链反应方案,从识别 11 种单独血清型和 10 个血清群改为四联格式,可识别 34 种单独血清型和 13 个小血清群、4 种抗生素耐药决定因素、菌毛靶标和青霉素敏感性。新开发的检测方法针对血清型/血清群特异性,灵敏度高(每个反应 10 个拷贝),并进一步将较大的血清群细分为单独的血清型或较小的血清群。